| Carly Ebert, OTD, OTR/L | |
|
3 Superior Dr Ste 225, Superior, CO 80027-8661 | |
| (303) 665-2603 | |
| Not Available |
| Full Name | Carly Ebert |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 3 Superior Dr Ste 225, Superior, Colorado |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255011300 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | OT.0008021 (Colorado) | Primary |
| Provider Name | Orthopedic Centers Of Colorado |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1801339502 PECOS PAC ID: 2365714540 Enrollment ID: O20170823001317 |
News Archive
How are non-heterosexual people affected by discrimination endured in the school environment due to their affective-sexual orientation? This question was the starting point in the PhD thesis produced by the researcher Aitor Martxueta.
Feelings of anxiety very effectively prevent people from getting into situations that are too dangerous. Those who have had a terrible experience initially tend to avoid the place of tragedy out of fear. If no other oppressive situation arises, normally the symptoms of fear gradually subside.
Six of the top scientists studying psoriasis-the most common autoimmune disease in the country, affecting 7.5 million Americans-and psoriatic arthritis, an inflammatory joint and tendon disease affecting up to 30 percent of people with psoriasis, received National Psoriasis Foundation (NPF) research grants totaling $450,000 for projects that aim to discover new treatments and a cure for these chronic diseases.
Moerae Matrix Inc. announced today the initiation of its second Phase 1 clinical trial with MMI-0100, a first-in-class inhibitor of MAPKAP kinase 2 (MK2) that is being developed for pulmonary disorders characterized by inflammation and fibrosis. The study, conducted in the United Kingdom, is a double-blind, two-way cross-over design lipopolysaccharide (LPS) challenge study further evaluating the safety and tolerability of MMI-0100 when given via inhalation to healthy subjects who smoke.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Carly Ebert, OTD, OTR/L 8101 E Lowry Blvd Ste 120, Denver, CO 80230-7195 Ph: (720) 865-6072 | Carly Ebert, OTD, OTR/L 3 Superior Dr Ste 225, Superior, CO 80027-8661 Ph: (303) 665-2603 |
News Archive
How are non-heterosexual people affected by discrimination endured in the school environment due to their affective-sexual orientation? This question was the starting point in the PhD thesis produced by the researcher Aitor Martxueta.
Feelings of anxiety very effectively prevent people from getting into situations that are too dangerous. Those who have had a terrible experience initially tend to avoid the place of tragedy out of fear. If no other oppressive situation arises, normally the symptoms of fear gradually subside.
Six of the top scientists studying psoriasis-the most common autoimmune disease in the country, affecting 7.5 million Americans-and psoriatic arthritis, an inflammatory joint and tendon disease affecting up to 30 percent of people with psoriasis, received National Psoriasis Foundation (NPF) research grants totaling $450,000 for projects that aim to discover new treatments and a cure for these chronic diseases.
Moerae Matrix Inc. announced today the initiation of its second Phase 1 clinical trial with MMI-0100, a first-in-class inhibitor of MAPKAP kinase 2 (MK2) that is being developed for pulmonary disorders characterized by inflammation and fibrosis. The study, conducted in the United Kingdom, is a double-blind, two-way cross-over design lipopolysaccharide (LPS) challenge study further evaluating the safety and tolerability of MMI-0100 when given via inhalation to healthy subjects who smoke.
› Verified 6 days ago
Melissa Luedke, OT Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 3 Superior Dr Ste 225, Superior, CO 80027 Phone: 303-665-2603 | |
Mrs. Ashley Brooke Branfort, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1995 E Coalton Rd, Apt. 76-103, Superior, CO 80027 Phone: 785-614-3707 | |
Patricia Lynn Treinen, M.S. O.T.R. Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1552 E Riverbend St, Superior, CO 80027 Phone: 303-543-2389 | |
Kari Smith, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1995 E Coalton Rd, Apartment 82-302, Superior, CO 80027 Phone: 570-337-0664 | |
Eric Scott Salus Jr., OT Occupational Therapist Medicare: Medicare Enrolled Practice Location: 2600 S Rock Creek Pkwy, Superior, CO 80027 Phone: 609-468-7465 | |
Tara Carine Carlson, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2127 Grayden Ct, Superior, CO 80027 Phone: 303-587-5526 |